跳至主要内容
临床试验/CTRI/2024/11/076979
CTRI/2024/11/076979尚未招募4 期

Endoscopic band ligation versus injection sclerotherapy in patients with bleeding internal hemorrhoids: a prospective randomised study

Neeraj Singla1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年12月1日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
To study the improvement in symptoms like bleeding, pain, prolapse.

研究概览

简要总结

Title

Endoscopic Band ligation versus injection sclerotherapy in patients with bleedinginternal hemorrhoids: a prospective randomised study.

|Objective

Primary objective- To compare the efficacy of Endoscopic band ligation and endoscopic Injection sclerotherapy procedures in patients with bleeding internal hemorrhoids.

Secondary objective- To test safety in terms of complications as a result of these procedures.

|Rationale

The rationale of this study is to compare the efficacy of two commonly used procedures for internal hemorrhoids. The results of this study will help clinicians in deciding which modality to use in patients presenting with bleeding internal hemorrhoids.

|Population

This prospective randomized controlled study will be done on patients presenting with rectal bleeding to the OPD/ IPD/ Emergency satisfying inclusion and exclusion criteria will be included.

|Design

This prospective randomized controlled study will be conducted at Fortis Hospital, Ludhiana from 1st July 2024 to 31st Dec, 2024. A total of 50 patients will be enrolled with 25 patients in each arm.

|Methodology

Patients presenting with symptoms will be screened for eligilibilty and informed written consent will be taken. Pre-procedural assessment with complete blood count, liver function tests, INR, TSH, HbA1c, and colonoscopy/sigmoidoscopy will be done on all the patients. Eligible patients as per inclusion criteria will be included in the trial and will be randomly allotted to one of the groups of RBL and IS procedure. Two arms: one with endoscopic band ligation, other with sclerotherapy using a sclerosant (polidochonol).

|Statistics

Data will be expressed as median and percentile values (5th, 25th, 75th and 95th      percentiles). The upper limit of normal will be defined as the 95th percentile of expected values. P≤0.05 will be considered statistically significant.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Symptomatic patients presenting with lower gastrointestinal bleed.
  • No age limit.

排除标准

  • Patients a known case or have previous history of chronic liver disease, liver cirrhosis, perianal or rectal surgery, anal fistula, perianal abscess, internal hemorrhoids infected or containing thrombi or inflammation, ulceration or gangrene, rectal or perianal malignancy, bleeding disorders, patients on antiplatelet or anticoagulant medications, pregnancy.

结局指标

主要结局

To study the improvement in symptoms like bleeding, pain, prolapse.

时间窗: three months

次要结局

  • To study any adverse events with any of the procedure(three months)

研究者

发起方
Neeraj Singla
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Neeraj Singla

First floor, Department of Gastroenterology, Fortis Hospital Ludhiana

研究点 (1)

Loading locations...

相似试验